KATHRYN MORALES: Open Payments
NPI 1801934385 · LYNWOOD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,243 in 47 payments from 10 companies in 2025. Trend: 2023 $1,174 · 2024 $1,204 · 2025 $1,243
Food & beverage: $1,243
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $339 |
| Novo Nordisk Inc | 16 | $332 |
| AstraZeneca Pharmaceuticals LP | 4 | $195 |
| Amgen Inc. | 2 | $171 |
| PFIZER INC. | 2 | $56 |
| Cranial Technologies, Inc | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 3 | $34 |
| Merck Sharp & Dohme LLC | 2 | $29 |
| SANOFI-AVENTIS U.S. LLC | 1 | $28 |
| Hologic Sales and Service, LLC | 1 | $25 |
Products named: Kerendia, Wegovy, REPATHA, BREZTRI, Ozempic, PREVNAR 20, FARXIGA, Rybelsus.
Industry payments across CA — which companies pay providers there.
